IL17A and diabetes mellitus: An increase in mortality of patients from IL-17 upregulation seems plausible, as upregulated IL-17A has been associated with acute respiratory distress syndrome (ARDS) and diseases that increase COVID-19 complications such as hypertension, diabetes, and obesity (176, 177).